BackAvalo Therapeutics Overview

Avalo Therapeutics Net Tangible Assets

Track Avalo Therapeutics's net tangible assets ($450M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$448.66M
↑ 329.04% YoYΔ $344.09M vs prior year quarter

Peer trimmed avg / median

Loading

Avalo Therapeutics Net Tangible Assets History

Loading

Avalo Therapeutics vs. peers: Net Tangible Assets Comparison

Loading

Avalo Therapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Avalo Therapeutics (AVTX) FAQ

As of the most recent data (June 2026), AVTX shows a net tangible assets of $450M. That compares with $100M in the prior-year period — up 329.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AVTX's net tangible assets is now $450M (was $100M) — a 329.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Avalo Therapeutics is outperforming or lagging.

Tracking AVTX's net tangible assets over time shows whether Avalo Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $450M That compares with $100M in the prior-year period — up 329.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Avalo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $450M) with ownership activity and broader fundamentals.

Avalo Therapeutics's net tangible assets is $450M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.